Physician

Abbass Shafii, M.D.

According to 2025 Medicare claims, Abbass Shafii, M.D. (NPI: 1548218662) practices gastroenterology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is UNITED MEDICAL DOCTORS (NPI: 1770559981; TIN: 200358722) and primary practice location at 92563-1405. Shafii is affiliated with the OptumCare ACO West (ACO ID: A5058), participating under the MSSP model.

Shafii's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 314 traditional Medicare patients, billed 737 HCPCS/CPT codes, and received $66,904 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 529 prescription claims across 338 beneficiaries totaling $18,030 in drug costs, led by Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg). 2019 DME data shows 109 claims. Open Payments data shows 47 records totaling $926. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $208,644 to $66,904. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $869,241 to $18,030. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	930	1,754	$208,644
2016	860	1,783	$173,581
2017	894	1,932	$180,377
2018	1,001	2,105	$222,531
2019	952	1,916	$172,940
2020	443	662	$72,704
2021	439	644	$79,111
2022	371	585	$66,103
2023	320	612	$61,226
2024	314	737	$66,904

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	1,028	$869,241
2016	268	851	$413,194
2017	348	745	$323,297
2018	522	891	$192,531
2019	361	584	$114,607
2020	247	479	$115,395
2021	533	799	$95,385
2022	387	554	$15,241
2023	425	649	$26,478
2024	338	529	$18,030

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	211	$124,950
2016	N/R	208	$122,972
2017	N/R	208	$125,707
2018	N/R	176	$87,372
2019	N/R	109	$57,642
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	63	63	$204
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$132
45380	Biopsy of large bowel using a flexible endoscope	112	112	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	78	$102
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	48	51	$77

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	198	300	$4,429
Clenpiq	Sod Picosulf/Mag Ox/Citric Ac	11	26	$1,899
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	24	37	$1,439
Sucralfate	Sucralfate	14	642	$1,347
Pantoprazole Sodium	Pantoprazole Sodium	147	8,180	$1,008

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$926	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abbass Shafii, M.D.?

Tedicare shows public-source Medicare data for Abbass Shafii, M.D. (NPI 1548218662), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abbass Shafii, M.D. have ACO affiliation data?

Abbass Shafii, M.D. is shown with ACO affiliation data for OptumCare ACO West (MSSP, ACO ID A5058).

What billing organization is linked to Abbass Shafii, M.D.?

Abbass Shafii, M.D. is linked to UNITED MEDICAL DOCTORS (billing NPI 1770559981) in the available physician profile data.

Does Abbass Shafii, M.D. have Open Payments data?

Abbass Shafii, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.